>Common Blood Pressure Drug Supercharges Cancer Treatment in Surprising New Study
Researchers at Dartmouth Cancer Center (DCC) have discovered that telmisartan, an FDA-approved medication commonly used to treat hypertension, can significantly enhance the tumor-killing effects of the targeted cancer drug olaparib.